The biology of lung cancer
- PMID: 2825849
The biology of lung cancer
Abstract
Detailed studies of both cell lines and fresh specimens of SCLC and NSCLC have demonstrated that considerable heterogeneity exists within each tumour with respect to morphology and the expression of a range of biomarkers. While retrospective studies suggest that the presence or absence of some of of some of these markers may be of clinical importance, future trials of lung cancer should assess these markers to determine their prospective value in predicting response to therapy, survival and cure from lung cancer.
Similar articles
-
Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.Oncogene. 1989 Jan;4(1):45-50. Oncogene. 1989. PMID: 2536917
-
Molecular genetics of small cell lung carcinoma.Semin Oncol. 2001 Apr;28(2 Suppl 4):3-13. Semin Oncol. 2001. PMID: 11479891 Review.
-
The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors.Am J Pathol. 1988 Dec;133(3):434-9. Am J Pathol. 1988. PMID: 2849299 Free PMC article.
-
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.Cancer Res. 2002 Jul 15;62(14):3971-9. Cancer Res. 2002. PMID: 12124329
-
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.Immunol Ser. 1990;53:453-68. Immunol Ser. 1990. PMID: 1966068 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical